Autopsy report · NCT03278808
Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis
Cause of deathRegulatory or ethics
“The IND has been withdrawn from FDA”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- U.S. Army Medical Research and Development Command
- Sponsor type
- US federal agency
- Conditions
- Malaria
- Interventions
- Chloroquine-Azithromycin (CQ/AZ); Chloroquine (CQ); atovaquone-proguanil (Malarone®)
- Participants
- 0
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
“No IND submitted to the FDA” - The Bronchiolitis in Hospitalized Infants Study
“The study was withdrawn with no participants enrolled due to the need for an IND from the FDA, which significantly expanded the scope of the study beyond what was originally anticipated for a pilot project within this network.” - Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation
“This study had been withdrawn by the sponsor as they are in process to approach FDA with rationale to get agency feedback and share written response on IRB query. Thereafter, they may again approach with new application and FDA written response.” - Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
“IND withdrawn” - Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers
“Drug development suspended by current holder of IND”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.